A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis.

Although the survival difference did not reach statistical significance, the hazard ratio of EZH2 LOF/EZH2 WT was 1.88, implying that subjects with an Ezh2 loss of function were almost twice as likely to succumb to the disease earlier as compared to those in the Ezh2 wild-type (WT) group.

also in 111,027 other papers